Site menu

Search by ticker code:
Generic filters

Menu

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

NZ acquisition puts the NIB (ASX:NHF) share price in focus

The NIB Holdings Limited (ASX: NHF) share price is under the spotlight after announcing an acquisition in New Zealand.

NIB makes Kiwi Insurance acquisition play

NIB has announced that it’s going to buy Kiwi Insurance for a total cost of approximately $43 million, or NZ$45 million in New Zealand dollars.

What does it do?

It was established in 2002 and offers life and living insurance products and services through Kiwibank.

If the transaction is allowed by regulators to go ahead, when NIB buys the business it will also enter into an exclusive relationship with KiwiBank – another business owned by the seller (Kiwi Group Holdings) – which will see the bank refer its retail customers to NIB for their life and living insurance needs.

Why is NIB buying Kiwi Insurance?

NIB’s management said the acquisition was aligned with the company’s “personalisation” strategy and would allow NIB NZ to provide health insurance members and Kiwibank customers with a wider set of products relevant to its “your better health”.

The company had been looking at opportunities in New Zealand for some time and is very confident that a more comprehensive and integrated offering would increase its market share in both health and life products, whilst growing revenue. The local living insurance market is reportedly twice the size of the health insurance market and has achieved consistent growth over the last decade.

The NIB Managing Director Mark Fitzgibbon said:

In New Zealand, living, life and health insurance are complementary products so often purchased as a package. We’re responding to this preference with what should be a more integrated and seamless experience for members and customers. And it means more people will benefit from the investment we’re making in more personalised health risk assessment and management.”

Summary thoughts on this deal and the NIB share price

NIB said it was going to fund the deal through a combination of existing capital and new debt. It’s expecting to add to profit per share, excluding one-off transaction costs, which are expected to be around NZ$8 million.

It seems like a smart bolt-on acquisition which will help diversify and improve the earnings in New Zealand.

With the NIB share price rising 60% over the last year, I’m not sure if it’s good value today or not after such a strong run. It’s hard to predict what’s going to happen in the private health insurance market in the longer-term, but this reduces NIB’s reliance a little on the Australian market.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content